Skip to main content
OpenTrials

Clinical trial condition

Spinal Muscular Atrophy

Explore clinical trials studying Spinal Muscular Atrophy. Study availability and eligibility vary by location and protocol.

113 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Spinal Muscular Atrophy trial results

Active, not recruiting

A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)

NCT05067790

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 22 locations
View Trial Details
Active, not recruiting

Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®

NCT04159987

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • CHU de Lyon Lyon, Auvergne-Rhône-Alpes, France
  • CHRU de Lille Lille, Hauts-de-France, France
  • CHU de Montpellier Montpellier, Occitanie, France
  • CHU de Toulouse Toulouse, Occitanie, France
View Trial Details
Active, not recruiting

Spinraza in Adult Spinal Muscular Atrophy

NCT03709784

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +11 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital-Harvard University Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients

NCT04690998

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • Service de Neurologie,Hôpital Raymond-Poincaré Garches, France
  • Département de Neurologie - CHRU Lille Lille, France
  • Service ENMG - Pathologies neuromusculaires, centre de référence en pathologie neuromusculaire Rhône-Alpes, Centre de référence SLA Lyon, France
  • CHU Montpellier Montpellier, France
View Trial Details

Related conditions